Ticker

6/recent/ticker-posts

cardiovascular drugs

 Types of Cardiovascular Drugs


1. Anti Anginal Drug

Classification of Anti-Anginal Drug

1. Nitrates

1. Short acting drug

Nitroglycerin or glyceryltrinitate (GTN)

2. Long acting drugs

Isosorbididinitrate

Isosorbidemononitrate


2. Beta-blockers

Atenolol

Propranolol

Metroprolol

Esmolol


3. Calcium (ca2+) channel blocker

1. Phenyl alkylamine

Verapamil

2. Benzothiazepine

Diltiazem

3. Dihydropyridines

Nifedipine

Nimodipine

Felodipine

Amlodipine

Nitrendipine

Lacidipine

Benidipine 


4. Potassium (k+) channel opner

Nicorandil

5. Others

Aspirin

Dipyridamole

Ranolazime



2. Anti hypertensive drugs


Classification of antihypertensive drug


1. Diuretics

a. Thiazide diuretics

Indapamide

Chlorothiazide

Hydrochlorothiazide

b. High ceiling diuretics

Furosemide 

c. Potassium sparing diuretics

Amiloride

Spironolactone



2. Drug acting on Renin- Angiotensin system

a. Angiotensin converting enzyme inhibitors (ACE inhibitors)

Captopril

Enalapril

Lisinopril

Ramipril

Fosinopril

Benazepril


b. Angiotensin ll receptor antagonist

Losartan

Candesartan

Valsartan

Omlesartan 


c. Renin- inhibitors aliskiren


3.  Sympatholytics

a. Centrally acting drugs

Clonidine

Methyldopa

b.  Adrenergic receptor blockers

I. Alpha - blockers 

Prazosin

Terazosin

Doxazosin

Il. Beta-blockers 

Propranolol

Atenolol


Ill. Alpha and Beta blockers

Labetalol


4. Calcium channel blockers


Verapamil

Nifedipine

Nicardipine

Nimodipine

Amlodipine


5. Dilators

a. Arteriolar dilators

Hydralazine

Minoxidil

Diazoxide

b. Vasodilators 

Gasious vasodilators; Nitric oxide

Nitroglycerin 


c. Arteriolar and venular dilators

Sodium nitroprusside



3. Anti- Arrhythmic Drugs


Classification of anti- Arrhythmic Drugs


1. Membrane stabilization Agents; Sodium (Na+) channel blockers

Quinidine

Procainamide

Lingnocaine


2. Anti - andrenergic agents

Beta blockers;

Propranolol

Esmolol

3. Agents widening AP action- potential;


Pottassium channel blockers;

Amiodarone

Ibutilide

Dofetilide

Sotalol

4. Calcium channel blocker


Verapamil

Diltiazem


5. Miscellaneous drugs

Digoxin; use for treatment for paroxysmal supraventricular tachycardia (PSVT)


Atropine; effective in the treatment of ventricular arrhythmias 



4. Cardiotonics Drug

a. Cardiac glycosides 

Digitoxin

Digoxin

Digitalis

b. Arjuna Bark


5. Lipid lowering Agents/ Hypolipidemic drugs/ Anti-hyperlipidemic drug



1. HMG COA reductase inhibitors (statins)

Lovastatin

Roscivastatin

Atorvastatin

Cerivastatin

Simvastatin

Pravastain

Pitavastain


2. Fibric acids

Gemfibrozil

Clofibrate

Fenofibrate

Cholestopol

Cholesevelam


3. Bile acid binding resins

Cholestyramine

Colestipol

4. Anti oxident

Probucol

5. Miscellaneous

Nicotinic acid

Neomycin

6. Sterol absorption

Ezetimibe



Drug use in Blood Disorder


1. Drug used in Coagulation

a. Vitamin K 

1. Vitamin K1; Phylloquinon (derived from plant)

Phytonadione 

2. Vitamin K2; Menaquinone  (produce in gut by bacteria)

3. Vitamin K3; Menadione (synthetic form)

Converted into Vitamin K2 in liver

Fat soluble; 

Menadione 

Acetomenadione

Water soluble;

Menadione

Sodium bisulfite


b. Miscellaneous drugs

Fibrinogen (factor l); obtain from human

Antihaemophilic factors (factor Vlll) essential blood clotting protein 

Adrenochrome monosemicarbazone

Rutin


c. Antifibrinolytic drugs



2. Anti coagulants Drugs

Classification of anticoagulant drug

1. Parenteral anticoagulants drugs

1. Indirect thrombininhibitors

Heparin

Low molecular weight heparin; Enoxaparin

Dalteparin

Reviparin

Fondaparinux


a. Heparinoids

Heparan sulfate

Dextran sulphate


2. Parenteral DTls (direct thrombin inhibitors)

Hirudin

Lepirudin

Argatroban


2. Oral anticoagulants drugs

a. Coumarin derivatives

Warfarin

Nicoumalone

b. Factor Xa inhibitors

Rivaroxaban

c. Oral DTIs

Dabigatran



3. Fibrinolytic drugs/ thrombolytic drug/Antithrombotic drugs


Streptokinase

Urokinase


4. Antiplatelet drugs 

Aspirin






Post a Comment

0 Comments